glioma

NCI Will Study Day One Biopharmaceuticals' Tovorafenib in Solid Tumors, Hematologic Cancers

NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling

Structural Variant Study Points to Pediatric Glioma Drivers, Prognostic Features

Day One Bio Raises $150M in Public Offering of Common Stock

Day One Seeks to Raise $125M in Common Stock Offering

NIH Launches New Childhood Cancer Genomics Program

Transgene, PersonGen Biotherapeutics to Study Oncolytic Virus, Cell Therapy Combo in Solid Tumors

Denovo Biopharma IDs Genetic Biomarker to Predict Brain Cancer Gene Therapy Response

Prediction Model IDs Brain Cancer Features That Contribute to Survival After CAR T-Cell Therapy

AstraZeneca's Lynparza Fails Phase II, Single-Arm Study in IDH-Mutant High-Grade Glioma

Day One Biopharmaceuticals Begins Pivotal Pan-RAF Inhibitor Trial in Pediatric Brain Cancer Patients

Day One Biopharmaceuticals Raises $130M in Series B Funding

Glioblastoma Transcriptomes Point to Mitochondrial Subtype, Potential Treatment Strategies

Mustang Bio, City of Hope Initiate Clinical Trial of CAR T-cell Therapy in Brain Cancer Patients

Ivy Brain Tumor Center Doses First Brain Cancer Patient in Study of QED Therapeutics' Infigratinib

Thermo Fisher Scientific, Agios Pharmaceuticals to Codevelop Glioma Companion Diagnostic

Targeted Therapies Continue to Yield Encouraging Data in Studies of IDH-Mutated AML, Glioma